SCHEMBL4904293

SCHEMBL4904293

CCN(c1nc(-c2ccc(F)cc2)sc1C)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TRPM8 Q7Z2W7 5/20 0.40
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
FFAR1 O14842 1/20 0.38
RARA P10276 1/20 0.38
RARB P10826 1/20 0.38
RARG P13631 1/20 0.38
MCL1 Q07820 1/20 0.38
ESR1 P03372 1/20 0.36
PTGS2 P35354 2/20 0.36
METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901463 0.92 ALDH1A1 (0.44) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4906118 0.91 LMNA (0.44) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4904348 0.91 LMNA (0.47) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4902506 0.90 LMNA (0.43) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4905594 0.90 TRPM8 (0.42) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4906968 0.90 PSEN1 (0.41) LMNAHSD17B10ALDH1A1ALOX15TRPM8
SCHEMBL4906619 0.90 LMNA (0.40) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4907121 0.89 LMNA (0.47) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4905802 0.89 LMNA (0.45) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4907195 0.89 LMNA (0.39) LMNAHSD17B10ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885HSD17B10 434/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885HSD17B10 434/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.